NewSquare Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-214
Closed -$36K – 343
2025
Q2
$36K Buy
214
+107
+100% +$15.9K ﹤0.01% 341
2025
Q1
$14.7K Buy
107
+88
+463% +$11.2K ﹤0.01% 443
2024
Q4
$2.25K Buy
+19
New +$2.22K ﹤0.01% 527
2023
Q1
– Sell
-45,557
Closed -$3.5M – 896
2022
Q4
$3.5M Buy
+45,557
New +$3.46M 0.44% 86
2020
Q3
– Sell
-40
Closed -$2K – 332
2020
Q2
$2K Buy
+40
New +$2.06K ﹤0.01% 309
2017
Q4
– Sell
-56
Closed -$4K – 333
2017
Q3
$4K Hold
56
– – ﹤0.01% 267
2017
Q2
$4K Hold
56
– – ﹤0.01% 253
2017
Q1
$5K Hold
56
– – ﹤0.01% 232
2016
Q4
$4K Sell
56
-7
-11% -$506 ﹤0.01% 258
2016
Q3
$5K Buy
+63
New +$5.09K ﹤0.01% 303

Other funds holding CAH

NewSquare Capital's CAH Position: Q3 2025 in Review

NewSquare Capital sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 214 shares — an estimated $36K sold.

NewSquare Capital first reported a position in CAH in Q3 2016 and held it in 10 quarters. The position peaked at $3.5M in Q4 2022. 1,225 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • NewSquare Capital reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 214 Cardinal Health shares in Q3 2025, an estimated $36K.
  • NewSquare Capital first reported a position in Cardinal Health in Q3 2016 and held it in 10 quarters.
  • NewSquare Capital's Cardinal Health position peaked at $3.5M in Q4 2022.
  • 1,225 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.